Name: BIIB Income Statement - Biogen Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

BIIB - Biogen Inc.

USD | NASDAQ | Healthcare

BIIB Income Statement - Biogen Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	2,477.8	2,279.4	2,534.7	2,645.5	2,431.0	2,454.7	2,465.8	2,464.9	2,290.5	2,386.3	2,530.3	2,456.0	2,463.0	2,544.0	2,508.5	2,589.1

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenues
Revenues	9,937.4	9,890.6	9,675.9	9,835.6	10,173.4	10,981.7	13,444.6	14,377.9	13,452.9	12,273.9	11,448.8	10,763.8	9,703.3	6,932.2	5,516.5	5,048.6	4,716.4	4,377.3
Cost of Revenue	2,435.9	2,404.2	2,310.4	2,533.4	2,278.3	2,109.7	1,805.2	1,955.4	1,816.3	1,630.0	1,478.7	1,240.4	1,171.0	857.7	545.5	466.8	400.3
Gross Profit	7,501.5	7,486.4	7,365.5	7,302.2	7,895.1	8,872.0	11,639.4	12,422.5	11,636.6	10,643.9	9,970.1	9,523.4	8,532.3	6,074.5	4,971.0	4,581.9
Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,334.9
Operating Income
Operating Income	-	-	-	-	-	2,840.7	4,550.1	7,042.6	5,888.6	5,345.8	5,151.7	4,891.0	3,972.4	2,515.5
Non-Operating
Interest Income	139.0	125.0	67.6	276.5	89.3	11.0	42.0	120.0	112.5	78.5	63.4	22.1	12.2	8.2	29.5
Tax & Net
Income Tax Expense	251.1	263.6	273.8	135.3	632.8	52.5	992.3	1,158.0	1,425.6	2,458.7	1,237.3	1,161.6	989.9	601.0	470.6
Per Share
EPS Basic	9.32	8.83	11.21	8.02	20.96	10.44	24.86	31.47	21.63	11.94	16.96	15.38	12.42	7.86	5.80	5.09
Supplementary Data
EBITDA	-	-	-	-	-	3,328.4	5,007.3	7,507.3	6,539.1	6,426.8	5,834.4	5,491.4	4,660.5	3,047.2	2,221.5	2,083.6

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling General & Administrative	607.3	682.5	594.8	583.8	572.5	680.0	588.4	553.8	581.5	608.5	788.2	548.0	605.0	632.8	563.3	572.6
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	204.4	463.3	66.5	66.9	183.2	381.1	72.7	71.9	147.5	253.9	64.1	64.5	112.3	243.9	64.2	67.2
Amortization of Intangibles	-	-	135.7	127.4	-	-	110.1	86.9	-	-	-	-	-	-	-	-	-
Other Operating Expenses	(19.7)	-	(34.1)	(48.7)	(68.4)	-	(14.8)	(85.2)	(93.7)	-	(300.0)	121.2	(69.4)	-	56.0	428.6	(263.3)
Total Operating Expenses	2,100.1	2,335.4	1,977.4	1,901.5	2,119.8	2,163.2	2,014.8	1,766.2	1,825.7	2,094.7	2,671.5	1,747.9	2,024.7	1,940.2	1,137.4

Operating Income
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	610.7	587.1	794.0	485.7	973.9	(330.7)	1,086.4	1,974.5	1,819.9	1,777.7	1,806.3	1,955.9	1,502.7	1,443.1	1,697.6	1,213.2	1,534.7	1,466.2	1,653.9	1,201.0	1,024.7	887.5	1,425.3	1,460.5

Non-Operating
Interest Income	37.9	37.2	31.6	32.3	23.9	18.5	11.6	20.1	17.4	23.8	95.9	75.9	80.9	49.9	23.9	12.6	2.9	2.8	2.6	2.7	2.9	4.0	6.0	7.6	24.4	29.2	30.5	29.1	31.2	31.1	26.0	28.7	26.7	24.3	20.6	16.9	16.7	20.4	16.4	15.4
Interest Expense	67.6	67.5	67.4	72.6	60.0	60.0	59.8	61.3	69.2	71.5	63.8	49.1	62.5	54.8	59.9	65.8	66.1	66.2
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	0.0	-	-	-	(3.3)
Other Non-Operating Income	(1.1)	(320.6)	15.8	(3.3)	2.5	(338.9)	(0.8)	(2.0)	(1.9)	(310.4)	(3.4)	(2.3)	0.6	396.0	1.7	(26.2)	(263.3)
Pre-Tax Income	377.7	(56.0)	557.3	744.0	311.2	291.5	451.0	698.7	464.8	291.6	(141.2)	708.1	438.3	603.8	1,371.1	1,269.5

Tax & Net
Income Tax Expense	58.2	(7.1)	90.8	109.2	70.7	24.8	62.5	115.1	71.4	42.7	(72.9)	114.8	50.7	54.3	236.2	216.7	125.6	443.3	(25.9)	(409.1)	44.2	13.4	240.8	446.1	292.0	276.1	211.3	248.1	422.5	469.6	369.8	263.7	322.5	1,566.1	383.8	269.6	239.2	190.3	337.0	353.6
Net Income From Continuing Ops	319.5	(48.9)	466.5	634.8	240.5	266.7	388.5	583.6	393.4	248.9	(68.3)	593.3	387.6	549.5	1,134.9	1,058.7	218.5
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	319.5	(48.9)	466.5	634.8	240.5	266.7	388.5	583.6	393.4	248.9	(68.3)	593.3	387.6	549.5	1,134.9	1,058.7	218.5
Net Income Attributable To Parent	319.5	(48.9)	466.5	634.8	240.5	266.7	388.5	583.6	393.4	249.7	(68.1)	591.6	387.9	550.4	1,134.7	1,058.0
Less: Minority Interest	-	-	-	-	-	0.0	0.0	0.0	0.0	(0.8)	(0.2)	1.7	(0.3)	(0.9)	0.2	0.7	(85.3)
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	319.5	(48.9)	466.5	634.8	240.5	266.7	388.5	583.6	393.4	249.7	(68.1)	591.6	387.9	550.4	1,134.7

Per Share
EPS Basic	2.17	-	3.18	4.33	1.65	-	2.67	4.01	2.71	-	(0.47)	4.09	2.69	-	7.86	7.25	2.06	-	2.22	3.00	2.70	-	4.47	9.60	8.10	-	8.40	7.85	7.17	-	7.17	4.18	5.55	-	5.80	4.07	3.47	-	4.72	4.79
EPS Diluted	2.15	-	3.17	4.33	1.64	-	2.66	4.00	2.70	-	(0.47)	4.07	2.67	-	7.84	7.24	2.06	-
Shares Basic	147.2	-	146.6	146.5	146.1	-	145.7	145.6	145.2	-	144.8	144.7	144.4	-	144.4	145.9	147.1	-
Shares Diluted	148.4	-	147.1	146.7	146.6	-	146.1	145.9	145.9	-	144.8	145.5	145.2	-	144.8	146.2	147.6	-

Supplementary Data
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	753.8	852.4	859.1	540.4	1,076.5	(96.2)	1,137.9	2,025.8	1,939.8	2,028.8	1,851.8	2,002.9	1,623.8	1,795.7	1,762.4	1,277.4	1,703.6	-	-	-	1,536.7	-	-	-
EBIT	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	610.7	587.1	794.0